Filing Flows › Boston Scientific (BSX) › Net income
Boston Scientific (BSX) net income by quarter
Boston Scientific's net income was $580M in Q3 2026 (third quarter 2026), -36% from Q2 2026. Over the last 7 quarters it ranged from $580M (Q3 2026) to $1.3B (Q1 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $580M | -36% | -23% |
| Q2 2026 | $905M | -32% | +14% |
| Q1 2026 | $1.3B | +100% | +99% |
| Q4 2025 | $670M | -11% | — |
| Q3 2025 | $755M | -5% | — |
| Q2 2025 | $795M | +18% | — |
| Q1 2025 | $672M | — | — |
Q3 2026 at a glance
Boston Scientific, Q3 2026: revenue $5.1B (+1% year over year), operating margin 16.1%, net earnings $580M, operating cash flow $1.0B. The chart follows the revenue to costs, profit and cash.
Questions
What is Boston Scientific's net income?
Boston Scientific's net income was $580M in Q3 2026 (third quarter 2026), -36% from Q2 2026.
How has Boston Scientific's net income changed?
Over the last 7 quarters it ranged from $580M (Q3 2026) to $1.3B (Q1 2026).